ConductScience.org, home

Paper14749129

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.

Lepourcelet M and 8 others. Cancer Cell, 2004. Cited by 563 papers, by iCite.

Cite this record

ConductScience Library. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Papers, record 14749129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14749129

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.
PubMed
Journal
Cancer Cell
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
563
iCite
Relative citation ratio, by iCite
10.2
iCite
Revised in PubMed
2022-03-11
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lepourcelet MMaina
2Chen YNYing-Nan P
3France DSDennis S
4Wang HHuisheng
5Crews PPhillip
6Petersen FFrank
7Bruseo CCharles
8Wood AWAlexander W
9Shivdasani RARamesh A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytoskeletal ProteinsMajor topic
DNA-Binding ProteinsMajor topic
Signal TransductionMajor topic
Trans-ActivatorsMajor topic
Transcription FactorsMajor topic
Animals
COS Cells
Cell Division
Chlorocebus aethiops
Combinatorial Chemistry Techniques
Cyclin D1
Protein Binding
Surface Plasmon Resonance
Xenopus
Xenopus Proteins
beta Catenin

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA52955NCI NIH HHSUnited StatesU01CA052955PubMed and NIHNIH RePORTER
U19CA052955NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in14749120Wnt breakers in colon cancer.https://conductscience.org/library/papers/14749120

Source PubMed

Download CSV of comments and corrections

Cited by287

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 563 citations.

PMIDTitleJournalYearIn PapersSource
42902746Natural products shape microbial ecology and disease in the cystic fibrosis airway.Nat Prod Rep2026https://conductscience.org/library/papers/42902746PubMed
41879495Emerging Roles of Small-molecule Derivatives in Modulating Neurodegenerative Pathways: From Molecular Targets to Therapeutic Applications.Mini Rev Med Chem2026https://conductscience.org/library/papers/41879495PubMed
41714442The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer.Oncogene2026https://conductscience.org/library/papers/41714442PubMed
41416436CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review).Int J Oncol2026https://conductscience.org/library/papers/41416436PubMed
41408288Nuclear β-catenin: molecular regulation, challenges and therapeutic opportunities.Cell Commun Signal2025https://conductscience.org/library/papers/41408288PubMed
41132024Downregulation of the Tumor Suppressor P53 Gene associated with the Progression of Clinical Staging and the Incidence of Distant Metastasis in Indonesian Colorectal Cancer.Korean J Gastroenterol2025https://conductscience.org/library/papers/41132024PubMed
41120801WNT signaling in cancer: molecular mechanisms and potential therapies.Mol Biomed2025https://conductscience.org/library/papers/41120801PubMed
40704280Molecular mechanisms underlying the inhibition of cell migration and invasion in endometriosis: Advances in pharmacological research (Review).Biomed Rep2025https://conductscience.org/library/papers/40704280PubMed
40240755Perspectives on cancer therapy-synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges.Cell Death Discov2025https://conductscience.org/library/papers/40240755PubMed
40180907Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40180907PubMed
40078400
Exploring the therapeutic potential of "Zhi-Zhen" formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatics, network pharmacology, and experimental validation.
Front Med (Lausanne)2025https://conductscience.org/library/papers/40078400PubMed
39766864Wnt Signaling Pathway in Tumor Biology.Genes (Basel)2024https://conductscience.org/library/papers/39766864PubMed
39725462Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma.Gut2025https://conductscience.org/library/papers/39725462PubMed
39614036Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions.Drug Deliv Transl Res2025https://conductscience.org/library/papers/39614036PubMed
39529066Emerging roles and biomarker potential of WNT6 in human cancers.Cell Commun Signal2024https://conductscience.org/library/papers/39529066PubMed
39404999Combinatorial Effects of 5-Fluorouracil and Menadione on Wnt/β-Catenin Pathway in Human Colorectal Cancer Cells.Appl Biochem Biotechnol2025https://conductscience.org/library/papers/39404999PubMed
38886806Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.J Hematol Oncol2024https://conductscience.org/library/papers/38886806PubMed
38045829Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.MedComm (2020)2023https://conductscience.org/library/papers/38045829PubMed
37783294Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials.Gene2024https://conductscience.org/library/papers/37783294PubMed
37749246Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities.Nat Genet2023https://conductscience.org/library/papers/37749246PubMed

See all 287 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
TCF46925PubTator's text mininghttps://conductscience.org/library/genes/6925NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14749129

GET https://conductscience.org/api/papers/v1/14749129/cited_by?page=2